 NEW YORK, Nov. 4, 2020 PRNewswire -- Actinium Pharmaceuticals, Inc. NYSE AMERICAN: ATNM Actinium today announced that data from the Phase 1 portion of the Actimab-A venetoclax Phase 12 combination trial, has been accepted for poster presentation at the 2020 American Society of... 